Literature DB >> 1513425

Proton magnetic resonance spectroscopy of pediatric brain tumors.

L N Sutton1, Z Wang, D Gusnard, B Lange, G Perilongo, A R Bogdan, J A Detre, L Rorke, R A Zimmerman.   

Abstract

1H magnetic resonance spectroscopy allows the regional quantitation of a number of metabolites from the brain in a noninvasive fashion. Spectra were obtained from 5 normal children and 25 children with brain tumors. Choline (Cho), N-acetylaspartate (NAA), creatine and phosphocreatine, and lactate were quantitated in the form of ratios. The brains of normal children showed relatively high concentrations of Cho and NAA and virtually no lactate, as has been shown in adults. Benign astrocytomas and ependymomas were characterized by an elevation of the Cho:NAA ratio and an abnormal accumulation of lactate. Intrinsic malignant tumors were remarkable for an even higher Cho:NAA ratio but had no more lactate than was found in the benign tumors. Proton magnetic resonance spectroscopy may prove useful in characterizing neoplastic tissue in conjunction with more conventional imaging modalities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513425     DOI: 10.1227/00006123-199208000-00004

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  17 in total

1.  Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas.

Authors:  J A Lazareff; C Olmstead; K H Bockhorst; J R Alger
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

Review 2.  Advances in the assessment of childhood brain tumors and treatment-related sequelae.

Authors:  Katherine E Warren
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

3.  Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging.

Authors:  A Aria Tzika; Maria K Zarifi; Liliana Goumnerova; Loukas G Astrakas; David Zurakowski; Tina Young-Poussaint; Douglas C Anthony; R Michael Scott; Peter McL Black
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

4.  Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part II: Clinical analysis.

Authors:  S E Byrd; T Tomita; P S Palka; C F Darling; J P Norfray; J Fan
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

5.  Combined MRI and MRS improves pre-therapeutic diagnoses of pediatric brain tumors over MRI alone.

Authors:  Mark S Shiroishi; Ashok Panigrahy; Kevin R Moore; Marvin D Nelson; Floyd H Gilles; Ignacio Gonzalez-Gomez; Stefan Blüml
Journal:  Neuroradiology       Date:  2015-07-04       Impact factor: 2.804

6.  Variation of post-treatment H-MRSI choline intensity in pediatric gliomas.

Authors:  J A Lazareff; R K Gupta; J Alger
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

7.  Intracranial tumors in children: small single-voxel proton MR spectroscopy using short- and long-echo sequences.

Authors:  A A Tzika; D B Vigneron; R S Dunn; S J Nelson; W S Ball
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

8.  MR imaging of glioblastoma in children: usefulness of diffusion/perfusion-weighted MRI and MR spectroscopy.

Authors:  Yun-Woo Chang; Hye-Kyung Yoon; Hyung-Jin Shin; Hong Gee Roh; Jae Min Cho
Journal:  Pediatr Radiol       Date:  2003-10-17

9.  Spectroscopy of untreated pilocytic astrocytomas: do children and adults share some metabolic features in addition to their morphologic similarities?

Authors:  Luciana Porto; Matthias Kieslich; Kea Franz; Thomas Lehrbecher; Stefan Vlaho; Ulrich Pilatus; Elke Hattingen
Journal:  Childs Nerv Syst       Date:  2009-12-20       Impact factor: 1.475

10.  Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma.

Authors:  Bayram Cirak; Alena Horská; Peter B Barker; Peter C Burger; Benjamin S Carson; Anthony M Avellino
Journal:  Childs Nerv Syst       Date:  2004-09-11       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.